Sonova Holding (OTCMKTS:SONVY – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 58,939 shares, an increase of 428.2% from the October 15th total of 11,158 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 52,624 shares, the short-interest ratio is currently 1.1 days.
Sonova Trading Down 0.2%
Shares of SONVY stock traded down $0.10 during trading hours on Wednesday, hitting $68.14. The company had a trading volume of 3,962 shares, compared to its average volume of 29,807. Sonova has a 12 month low of $42.26 and a 12 month high of $71.91. The company has a current ratio of 1.75, a quick ratio of 1.43 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average is $62.62 and its 200 day moving average is $53.71.
Wall Street Analyst Weigh In
A number of brokerages recently commented on SONVY. Citigroup restated a “sell” rating on shares of Sonova in a research note on Friday, July 24th. UBS Group cut shares of Sonova from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 2nd. Royal Bank Of Canada downgraded shares of Sonova from a “moderate buy” rating to a “hold” rating in a report on Friday, November 6th. Finally, The Goldman Sachs Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold”.
Sonova Company Profile
Sonova is a Switzerland-based hearing care company headquartered in Stäfa. Founded in 1947 as AG für Elektroakustik, it has grown into a global provider of products and services for people with hearing loss. The company develops and sells hearing aids under brands including Phonak and Unitron, as well as cochlear implant systems through Advanced Bionics. Its offerings also include wireless hearing solutions and consumer audio products sold under the Sennheiser brand. Sonova serves customers worldwide through product sales and audiological care services, including hearing assessments, fittings and ongoing support.
See Also
- Five stocks we like better than Sonova
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
- Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
